QuickLinks -- Click here to rapidly navigate through this document

As filed with the Securities and Exchange Commission on July 28, 2003.

Registration No. 333-            



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM S-8

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933


BRISTOL-MYERS SQUIBB COMPANY

(Exact name of registrant as specified in its charter)


Delaware
(State or other jurisdiction of incorporation or organization)


22-079-0350
(I.R.S. Employer Identification No.)


345 Park Avenue, New York, N.Y. 10154
(Address, including zip code, of Principal Executive Offices)

Telephone: (212) 546-4000


BRISTOL-MYERS SQUIBB COMPANY 2002 STOCK INCENTIVE PLAN,
As Amended Effective July 17, 2002
BRISTOL-MYERS SQUIBB COMPANY 1997 STOCK INCENTIVE PLAN,
As Amended Effective July 17, 2002
BRISTOL-MYERS SQUIBB COMPANY 2000 NON-EMPLOYEE DIRECTORS' STOCK OPTION PLAN,
Effective As of May 2, 2000
BRISTOL-MYERS SQUIBB COMPANY EXECUTIVE PERFORMANCE INCENTIVE PLAN,
Effective as of January 1, 2003
BRISTOL-MYERS SQUIBB COMPANY EMPLOYEE INCENTIVE THRIFT PLAN
BRISTOL-MYERS SQUIBB PUERTO RICO, INC. SAVINGS AND INVESTMENT PROGRAM
BRISTOL-MYERS SQUIBB COMPANY SAVINGS AND INVESTMENT PROGRAM
(Full title of the plans)


John L. McGoldrick
Executive Vice President and General Counsel
Bristol-Myers Squibb Company
345 Park Avenue, New York, N.Y. 10154
(212) 546-4000
(Name, address and telephone number, including area code, of agent for service)





Copies To:

Sandra Leung
Vice President and Corporate Secretary
Bristol-Myers Squibb Company
345 Park Avenue, New York, N.Y. 10154
(212) 546-4000


CALCULATION OF REGISTRATION FEE


Title of Securities to be Registered(1)
  Amount to be Registered(1)
  Proposed Maximum Offering Price Per Unit(2)
  Proposed Maximum Aggregate Offering Price
  Amount of Registration Fee(3)

Common Stock, par value $0.10 per share   132,515,000 shares   $25.64   $3,397,684,600   $274,872.68

        (1)   This registration statement (the "Registration Statement") registers the offer and sale of up to 132,515,000 shares of Common Stock of Bristol-Myers Squibb Company, a Delaware corporation (the "Company"), under the plans listed above. In addition, pursuant to Rule 416(b), the Registration Statement registers an indeterminate amount of interests to be offered or sold pursuant to the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, Bristol-Myers Squibb Puerto Rico, Inc. Savings and Investment Plan, and Bristol-Myers Squibb Company Savings and Investment Program. Pursuant to Rule 416(a), the number of shares being registered shall be adjusted to include any additional shares which may become issuable as a result of stock splits, stock dividends or similar transactions in accordance with the anti-dilution provisions of the Plan. Attached to the Common Stock are certain rights to purchase Series A Junior Participating Preferred Stock upon the occurrence of specified events.

        (2)   Estimated pursuant to paragraphs (c) and (h) of Rule 457 solely for the purpose of calculating the registration fee, based upon the average of the reported high and low sales prices for shares of Common Stock on July 23, 2003, as reported on the composite tape for New York Stock Exchange-listed securities.

        (3)   Calculated pursuant to Section 6(b) of the Securities Act of 1933, as amended, as follows: $80.90 per $1 million of proposed maximum aggregate offering price.



PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS


Item 1. Plan Information.

        Omitted as permitted pursuant to Rule 428 and Form S-8.


Item 2. Registrant Information.

        Omitted as permitted pursuant to Rule 428 and Form S-8.

2



PART II

INFORMATION REQUIRED IN REGISTRATION
STATEMENT AND NOT REQUIRED IN PROSPECTUS


Item 3. Incorporation of Documents by Reference

        The following documents which have heretofore been filed by Bristol-Myers Squibb Company (the "Company") (File No. 001-01136) with the Securities and Exchange Commission (the "Commission") pursuant to the Securities Exchange Act of 1934, as amended (the "1934 Act"), are incorporated by reference herein and shall be deemed to be a part hereof:

        (a)   The Company's Annual Report on Form 10-K for the Company's fiscal year ended December 31, 2002.

        (b)   The Company's Quarterly Report on Form 10-Q for the Company's fiscal quarter ended March 31, 2003.

        (c)   Each of the Company's Current Reports on Form 8-K filed with the Commission since December 31, 2002.

        (d)   The description of the Company's Common Stock contained in a Registration Statement filed under the 1934 Act, including any amendment or report filed for the purpose of updating such description.

        (e)   The Annual Report on Form 11-K for the fiscal year ended December 31, 2002 of each of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, Bristol-Myers Squibb Puerto Rico, Inc. Savings and Investment Plan, as amended, and Bristol-Myers Squibb Company Savings and Investment Program (these three plans being the "Savings/Thrift Plans").

        All documents filed by the Company and the Savings/Thrift Plans with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and made a part hereof from their respective dates of filing (such documents, and the documents enumerated above, being hereinafter referred to as "Incorporated Documents"); provided, however, that the documents enumerated above or subsequently filed by the Company and the Savings/Thrift Plans pursuant to Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act in each year during which the offering made by this Registration Statement is in effect prior to the filing with the Commission of the Company's Annual Report on Form 10-K or, in the case of each Savings/Thrift Plan, the filing with the Commission of that Savings/Thrift Plan's Annual Report on Form 11-K covering such year shall not be Incorporated Documents or be incorporated by reference in this Registration Statement or be a part hereof from and after the filing of such Annual Report on Form 10-K or Annual Report on Form 11-K.

        Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.


Item 4. Description of Securities

        Not applicable. See Item 3 above.

3



Item 5. Interests of Named Experts and Counsel

        The legality of the securities offered pursuant to this Registration Statement has been passed upon for the Company by John L. McGoldrick, Executive Vice President and General Counsel of the Company, 345 Park Avenue, New York, New York 10154. Mr. McGoldrick is an officer of the Company and owns, and has options to purchase, shares of common stock of the Company, and participates in and owns interests under one or more of the Savings/Thrift Plans.


Item 6. Indemnification of Directors and Officers

        Section 145 of the Delaware General Corporation Law (the "DGCL") provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement in connection with specified actions, suits or proceedings, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation—a "derivative action"), if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal actions or proceedings, had no reasonable cause to believe their conduct was unlawful. A similar standard is applicable in the case of derivative actions, except that indemnification only extends to expenses (including attorneys' fees) actually and reasonably incurred in connection with the defense or settlement of such action, and the DGCL requires court approval before there can be any indemnification where the person seeking indemnification has been found liable to the corporation. The DGCL provides that it is not exclusive of other indemnification that may be granted by a corporation's by-laws, disinterested director vote, stockholder vote, agreement or otherwise.

        Under the terms of the Company's Bylaws and subject to the applicable provisions of the laws of the State of Delaware, the Company is obligated to indemnify each of its directors and officers, and any employee of the Company who, at the Company's request, has served as a director or officer of another corporation in which the Company owns capital or of which it is a creditor, against expenses incurred or paid in connection with any claim made against such director or officer or any actual or threatened action, suit or proceeding in which such director or officer may be involved by reason of being or having been a director or officer of the Company, or of serving or having served at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action taken or not taken by such director or officer in such capacity, and against the amount or amounts paid by such director or officer in settlement of any such claim, action, suit or proceeding or any judgment or order entered therein.

        Section 102(b)(7) of the DGCL permits a provision in the certificate of incorporation of each corporation organized thereunder, such as the Company, eliminating or limiting, with certain exceptions, the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. The Restated Certificate of Incorporation of the Company eliminates the liability of directors to the extent permitted by the DGCL.

        The Company carries directors' and officers' liability insurance that covers certain liabilities and expenses of the Company's directors and officers.


Item 7. Exemption from Registration

        Not applicable.

4



Item 8. Exhibits

Exhibit
  Description
4a   Restated Certificate of Incorporation of Bristol-Myers Squibb Company (incorporated herein by reference to Exhibit 4a to the Company's Registration Statement on Form S-3, Registration Statement No. 33-33682, dated March 7, 1990, as amended as of May 5, 1999 by Certificate of Amendment incorporated herein by reference to Exhibit 3a to Form 10-K for the fiscal year ended December 31,1999, as amended as of May 29, 2003 by Certificate of Amendment filed herewith).

4b

 

Bylaws of Bristol-Myers Squibb Company, as amended as of June 10, 2003 (filed herewith).

5

 

Opinion of the Company's Executive Vice President and General Counsel as to the legality of the Common Stock offered hereby (the Company hereby undertakes that it will submit or has submitted each of the Savings/Thrift Plans and any amendment thereto to the Internal Revenue Service ("IRS") in a timely manner and has made or will make all changes required by the IRS as necessary in order to qualify each such Plan under Section 401 of the Internal Revenue Code).

15

 

Letter re: Unaudited Financial Information.

23a

 

Consent of Independent Accountants, PricewaterhouseCoopers LLP.

23b

 

Consent of Counsel (contained in the Opinion of the Company's Executive Vice President and General Counsel, Exhibit 5 hereto).

24

 

Powers of Attorney (included on the signature pages of this Registration Statement).

99

 

Not applicable.


Item 9. Undertakings

        (a)   The undersigned registrants hereby undertake:

5


        (b)   The undersigned registrants hereby undertake that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

        (c)   Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrants pursuant to the foregoing provisions, or otherwise, the registrants have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrants of expenses incurred or paid by a director, officer or controlling person of the registrants in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrants will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

6



EXPERTS

        The financial statements incorporated in this Registration Statement by reference to the Annual Report on Form 10-K of Bristol-Myers Squibb Company for the year ended December 31, 2002 and to the Annual Report on Form 11-K for the year ended December 31, 2002 of each of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, Bristol-Myers Squibb Puerto Rico, Inc. Savings and Investment Plan, as amended, and Bristol-Myers Squibb Company Savings and Investment Program, have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting.

        With respect to the unaudited financial information of Bristol-Myers Squibb for the three month periods ended March 31, 2003 and 2002, incorporated by reference in this Registration Statement, PricewaterhouseCoopers LLP reported that they have applied limited procedures in accordance with professional standards for a review of such information. However, their separate report dated May 2, 2003 incorporated by reference herein states that they did not audit and they did not express an opinion on that unaudited financial information. Accordingly the degree of reliance on their report on such information should be restricted in light of the limited nature of the review procedures applied. PricewaterhouseCoopers LLP is not subject to the liability provisions of Section 11 of the Securities Act of 1933 for their report on the unaudited financial information because that report is not a "report" or a "part" of the Registration Statement prepared or certified by PricewaterhouseCoopers LLP within the meaning of Section 7 and 11 of the Act.


SIGNATURES

        The Registrant.    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in City of New York, and the State of New York, on July 28, 2003.

    BRISTOL-MYERS SQUIBB COMPANY

 

 

By:

/s/  
PETER R. DOLAN      
Peter R. Dolan
Chairman of the Board and Chief Executive Officer

        Each person whose signature appears below hereby severally constitutes and appoints John L. McGoldrick and Sandra Leung, and each of them acting singly, as his or her true and lawful attorney-in-fact and agent, with full and several power of substitution and resubstitution, to sign for him or her and in his or her name, place and stead, in any and all capacities indicated below, the registration statement on Form S-8 filed herewith and any and all pre-effective and post-effective amendments and supplements to said registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his or her substitute, may lawfully do or cause to be done by virtue thereof.

7


        Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities indicated on July 28, 2003.

Signature
  Title


 


 


 

/s/  
PETER R. DOLAN      
Peter R. Dolan

 

Chairman of the Board, Chief Executive Officer, and Director (Principal Executive Officer)

/s/  
ANDREW R. J. BONFIELD      
Andrew R. J. Bonfield

 

Senior Vice President and Chief Financial Officer (Principal Bonfield Financial Officer)

/s/  
DAVID L. ZABOR      
David L. Zabor

 

Vice President and Controller (Principal Accounting Officer)

/s/  
ROBERT E. ALLEN      
Robert E. Allen

 

Director

/s/  
LEWIS B. CAMPBELL      
Lewis B. Campbell

 

Director

/s/  
VANCE D. COFFMAN      
Vance D. Coffman

 

Director

/s/  
ELLEN V. FUTTER      
Ellen V. Futter

 

Director

/s/  
LOUIS V. GERSTNER, JR.      
Louis V. Gerstner, Jr.

 

Director

/s/  
LAURIE H. GLIMCHER, M.D.      
Laurie H. Glimcher, M.D.

 

Director

/s/  
LEIF JOHANSSON      
Leif Johansson

 

Director

/s/  
JAMES D. ROBINSON, III      
James D. Robinson III

 

Director

/s/  
LOUIS W. SULLIVAN, M.D.      
Louis W. Sullivan, M.D.

 

Director

8


        The Savings/Thrift Plans. Pursuant to the requirements of the Securities Act of 1933, the trustees (or other persons who administer the Savings/Thrift Plans) have duly caused this Registration Statement to be signed on behalf of each of the Savings/Thrift Plans by the undersigned, thereunto duly authorized, in the City of New York, and the State of New York, on July 28, 2003.

Bristol-Myers Squibb Company Employee Incentive Thrift Plan

Bristol-Myers Squibb Puerto Rico, Inc. Savings and Investment Plan

Bristol-Myers Squibb Company Savings and Investment Program.

By:    Bristol-Myers Squibb Company
Savings Plan Committee

Signature
  Title


 


 


 

/s/  
HARRISON M. BAINS, JR.      
Harrison M. Bains, Jr.

 

Vice President, Tax and Treasury *

/s/  
STEPHEN E. BEAR      
Stephen E. Bear

 

Senior Vice President, Human Resources *

/s/  
ANDREW R. J. BONFIELD      
Andrew R. J. Bonfield

 

Senior Vice President and Chief Financial Officer *

/s/  
ROBERT B. CHAPMAN, JR.      
Robert B. Chapman, Jr.

 

Assistant Treasurer *

/s/  
SANDRA LEUNG      
Sandra Leung

 

Vice President and Corporate Secretary *

/s/  
ANTHONY F. MAZZEO      
Anthony F. Mazzeo

 

Vice President, Global Benefits *

/s/  
JOHN L. MCGOLDRICK      
John L. McGoldrick

 

Executive Vice President and General Counsel *

/s/  
DAVID L. ZABOR      
David L. Zabor

 

Vice President and Controller *

*
Members of Bristol-Myers Squibb Company Savings Plan Committee, signing in that capacity on behalf of the Bristol-Myers Squibb Company Savings and Investment Program, the Bristol-Myers Squibb Company Employee Incentive Thrift Plan and the Bristol-Myers Squibb Puerto Rico, Inc. Savings and Investment Program.

9


EXHIBIT INDEX

Exhibit

  Description

  Sequentially
Numbered Page


4a

 

Restated Certificate of Incorporation of Bristol-Myers Squibb Company (incorporated herein by reference to Exhibit 4a to the Company's Registration Statement on Form S-3, Registration Statement No. 33-33682, dated March 7, 1990), as amended as of May 5, 1999 by Certificate of Amendment incorporated herein by reference to Exhibit 3a to Form 10-K for the fiscal year ended December 31,1999, as amended as of May 29, 2003 by Certificate of Amendment filed herewith).

 

 

4b

 

Bylaws of Bristol-Myers Squibb Company, as amended as of June 10, 2003 (filed herewith).

 

 

5

 

Opinion of the Company's Executive Vice President and General Counsel as to the legality of the Common Stock offered hereby (the Company hereby undertakes that it will submit or has submitted each of the Savings/Thrift Plans and any amendment thereto to the Internal Revenue Service ("IRS") in a timely manner and has made or will make all changes required by the IRS as necessary in order to qualify each such Plan under Section 401 of the Internal Revenue Code).

 

 

15

 

Letter re: Unaudited Financial Information.

 

 

23a

 

Consent of Independent Accountants, PricewaterhouseCoopers LLP.

 

 

23b

 

Consent of Counsel (contained in the Opinion of the Company's Executive Vice President and General Counsel, Exhibit 5 hereto).

 

 

24

 

Powers of Attorney (included on the signature pages of this Registration Statement).

 

 



QuickLinks

PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT AND NOT REQUIRED IN PROSPECTUS
EXPERTS
SIGNATURES